Fundraising Fox

IVIEW Therapeutics

Cranbury, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

WW
Wei WangExecutive Officer, Director
BL
Bo LiangExecutive Officer, Director
HH
Houman HemmatiExecutive Officer, Director
JJ
John J BaldwinDirector
TD
Tao DuDirector
QZ
Qi ZhuDirector
JL
Jingjie LiDirector
XS
Xiaolu SunDirector
BH
Bin HeDirector

Investors · 1

BioAdvanceConshohocken · $500K – $1.5M

Reported raises · per SEC filings

Form D private placements
▶$9.2MraisedJun 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Qi ZhuDirector
  • Houman HemmatiExecutive Officer, Director
  • Wei WangExecutive Officer, Director
  • Jingjie LiDirector
  • Xiaolu SunDirector
  • Bo LiangExecutive Officer, Director
  • Bin HeDirector
Offering amount
$15M
Amount sold
$9.2M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedJan 2022 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John J BaldwinDirector
  • Wei WangExecutive Officer, Director
  • Bo LiangExecutive Officer, Director
  • Qi ZhuExecutive Officer, Director
  • Xiaolu SunDirector
  • Bin HeDirector
  • Tao DuDirector
Offering amount
$30M
Amount sold
$30M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.